|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morgensztern D, Ng SH, Gao F and Govindan
R: Trends in stage distribution for patients with non-small cell
lung cancer: A National Cancer Database survey. J Thorac Oncol.
5:29–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun QL, Sha HF, Yang XH, Bao GL, Lu J and
Xie YY: Comparative proteomic analysis of paclitaxel sensitive A549
lung adenocarcinoma cell line and its resistant counterpart
A549-Taxol. J Cancer Res Clin Oncol. 137:521–532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khongkow P, Gomes AR, Gong C, Man EP,
Tsang JW, Zhao F, Monteiro LJ, Coombes RC, Medema RH, Khoo US, et
al: Paclitaxel targets FOXM1 to regulate KIF20A in mitotic
catastrophe and breast cancer paclitaxel resistance. Oncogene.
35:990–1002. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park SH, Seong MA and Lee HY: p38
MAPK-induced MDM2 degradation confers paclitaxel resistance through
p53-mediated regulation of EGFR in human lung cancer cells.
Oncotarget. 7:8184–8199. 2016.PubMed/NCBI
|
|
6
|
Holleman A, Chung I, Olsen RR, Kwak B,
Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE and Zetter BR:
miR-135a contributes to paclitaxel resistance in tumor cells both
in vitro and in vivo. Oncogene. 30:4386–4398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirano T, Yoshikawa R, Harada H, Harada Y,
Ishida A and Yamazaki T: Long noncoding RNACCDC26, controls myeloid
leukemia cell growth through regulation of KIT expression. Mol
Cancer. 14:902015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Wu K, Yang Z, Zhao Q and Fan D, Xu
P, Nie Y and Fan D: Multidrug-resistance related long non-coding
RNA expression profile analysis of gastric cancer. PLoS One.
10:e01354612015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren S, Li G, Liu C, Cai T, Su Z, Wei M,
She L, Tian Y, Qiu Y, Zhang X, et al: Next generation deep
sequencing identified a novel lncRNA n375709 associated with
paclitaxel resistance in nasopharyngeal carcinoma. Oncol Rep.
36:1861–1867. 2016.PubMed/NCBI
|
|
10
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong S, Qu X, Li W, Zhong X, Li P, Yang S,
Chen X, Shao M and Zhang L: The long non-coding RNA GAS5, enhances
gefitinib-induced cell death in innate EGFR tyrosine kinase
inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR
via downregulation of the the via downregulation of the IGF-1R
expression. J Hematol Oncol. 8:432015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao C, Zhang J, Wang Q and Ren C:
Overexpression of lncRNA NEAT1 mitigates multidrug resistance by
inhibiting ABCG2 in leukemia. Oncol Lett. 12:1051–1057.
2016.PubMed/NCBI
|
|
15
|
Ding J, Li D, Gong M, Wang J, Huang X, Wu
T and Wang C: Expression and clinical significance of the long
non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther.
7:1625–1630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang CL, Zhu KP, Shen GQ and Zhu ZS: A
long non-coding RNA contributes to doxorubicin resistance of
osteosarcoma. Tumour Biol. 37:2737–2748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Snow K and Judd W: Characterisation of
adriamycin- and amsacrine-resistant human leukaemic T cell lines.
Br J Cancer. 63:17–28. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu R, Liu X, Zheng Y, Gu J, Xiong S,
Jiang P, Jiang X, Huang E, Yang Y, Ge D, et al: MicroRNA-7
sensitizes non-small cell lung cancer cells to paclitaxel. Oncol
Lett. 8:2193–2200. 2014.PubMed/NCBI
|
|
19
|
Chatterjee A, Chattopadhyay D and
Chakrabarti G: miR-17-5p downregulation contributes to paclitaxel
resistance of lung cancer cells through altering beclin1
expression. PLoS One. 9:e957162014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee H, Kim C, Ku JL, Kim W, Yoon SK, Kuh
HJ, Lee JH, Nam SW and Lee EK: A long non-coding RNA snaR
contributes to 5-fluorouracil resistance in human colon cancer
cells. Mol Cells. 37:540–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
You L, Chang D, Du HZ and Zhao YP:
Genome-wide screen identifies PVT1 as a regulator of Gemcitabine
sensitivity in human pancreatic cancer cells. Biochem Biophys Res
Commun. 407:1–6. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang S, Gao H, Tong Y, Yang J, Tang R, Niu
Y, Li M and Guo L: Long noncoding RNA-HOTAIR affects
chemoresistance by regulating HOXA1 methylation in small cell lung
cancer cells. Lab Invest. 96:60–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiao F, Hu H, Han T, Yuan C and Wang L,
Jin Z, Guo Z and Wang L: Long noncoding RNA MALAT-1 enhances stem
cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci.
16:6677–6693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. EExp Biol Med. 241:644–649. 2016. View Article : Google Scholar
|
|
25
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21WAF1/CIP1 expression. PLoS One. 8:e772932013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aldonza MB, Hong JY, Bae SY, Song J, Kim
WK, Oh J, Shin Y, Lee SH and Lee SK: Correction: Suppression of
MAPK signaling and reversal of mTOR-dependent MDR1-associated
multidrug resistance by 21α-methylmelianodiol in lung cancer cells.
PLoS One. 10:e01278412015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. FEBS J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng N, Li X, Zhao C, Ren S, Chen X, Cai
W, Zhao M, Zhang Y, Li J, Wang Q, et al: Microarray expression
profile of long non-coding RNAs in EGFR-TKIs resistance of human
non-small cell lung cancer. Oncol Rep. 33:833–839. 2015.PubMed/NCBI
|
|
29
|
Yang X, Zhang Y, Hosaka K, Andersson P,
Wang J, Tholander F, Cao Z, Morikawa H, Tegnér J, Yang Y, et al:
VEGF-B promotes cancer metastasis through a VEGF-A-independent
mechanism and serves as a marker of poor prognosis for cancer
patients. Proc Natl Acad Sci USA. 112:E2900–E2909. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Su HY, Lai HC, Lin YW, Liu CY, Chen CK,
Chou YC, Lin SP, Lin WC, Lee HY and Yu MH: Epigenetic silencing of
SFRP5 is related to malignant phenotype and chemoresistance of
ovarian cancer through Wnt signaling pathway. Int J Cancer.
127:555–567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiong W, Jiang YX, Ai YQ, Liu S, Wu XR,
Cui JG, Qin JY, Liu Y, Xia YX, Ju YH, et al: Microarray analysis of
long non-coding RNA expression profile associated with
5-fluorouracil-based chemoradiation resistance in colorectal cancer
cells. Asian Pac J Cancer Prev. 16:3395–3402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu Y, Yu DD, Hu Y, Yan D, Chen X, Cao HX,
Yu SR, Wang Z and Feng JF: Genome-wide profiling of long non-coding
RNA expression patterns in the EGFR-TKI resistance of lung
adenocarcinoma by microarray. Oncol Rep. 35:3371–3386.
2016.PubMed/NCBI
|
|
33
|
Zhu KP, Zhang CL, Shen GQ and Zhu ZS: Long
noncoding RNA expression profiles of the doxorubicin-resistant
human osteosarcoma cell line MG63/DXR and its parental cell line
MG63 as ascertained by microarray analysis. Int J Clin Exp Pathol.
8:8754–8773. 2015.PubMed/NCBI
|
|
34
|
Zhou M, Ye Z, Gu Y, Tian B, Wu B and Li J:
Genomic analysis of drug resistant pancreatic cancer cell line by
combining long non-coding RNA and mRNA expression profling. Int J
Clin Exp Pathol. 8:38–52. 2015.PubMed/NCBI
|
